… Prophylactic HPV vaccination might have a large effect on the control of HPV-associated …
We conclude that if prophylactic HPV vaccination is widely implemented, approximately one …

… vaccine was 14.4%–23.8% for LSIL, and 19.0%–32.8% for HSIL. The benefit of the nonavalent
vaccine compared to the quadrivalent vaccine … HPV vaccines to a nonavalent vaccine …

… different HPV genotypes is changing after HPV vaccination. … abnormality, as well as HPV
type specific risks for cytological … to large-scale use of HPV vaccines. Our study was conducted …

… Conversely, controlling for HPV type, the absolute risk for subsequent CIN3 of HPV-positive
ASCUS is equivalent to that for low-grade squamous intraepithelial lesion (LSIL).11 It is …

… years and catch-up vaccination to 26 years. Licensed HPV vaccines are effective in preventing
HPV infection prior to exposure and vaccination prior to initiating sexual activity optimizes …

… accurate assessment of HPV vaccine effectiveness. In this study, we evaluated cervical
intraepithelial lesions, rather than verifying the efficacy of HPV vaccines to prevent HPV infection. …

… three-dose, quadrivalent HPV vaccine is a potential … HPV vaccines demonstrate therapeutic
response for treating anogenital warts, cervical intraepithelial neoplasia, anal intraepithelial …

… and other intraepithelial cervical lesions that can … intraepithelial lesions associated with
papillomavirus infection. A total of 1176 female and 180 male patients with intraepithelial lesions …

… , are defined by cytology as low-grade squamous intraepithelial lesion (… HPV vaccination
status, HPV DNA status, and other HPV-associated clinical outcomes to evaluate HPV vaccine …

… nationwide registers for individual-level information about HPV vaccination and first diagnoses
of vulvar and vaginal high-grade squamous intraepithelial lesions (HSIL+) or worse. The …